Login

Sander Geophysics receives the 202 Employer Award.|Luise Sander is co-presidents of Sander Geophysics 00:10:00

Share On Facebook Share On Twitter

Luise Sander is co-presidents of Sander Geophysics

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Valor Resources (ASX: VAL) is progressing its Canadian uranium projects, as highlighted by executive chairman George Bauk during an interview with Wally Graham of The Resources Roadhouse at the RIU Resurgence 2023 Conference in Perth.|GEORGE BAUK, EXECUTI
00:10:00
Optimal Maintenance Management of a UE Engine involves implementing efficient strategies to ensure maximum performance, reliability, and longevity while minimizing downtime and costs.
00:10:00
Chatham Rock Phosphate CEO Discusses Key Projects and Market Potential
00:10:00
Deglobalization & Contract Manufacturing with Hanza | Erik Stenfors - CEO of Hanza AB
00:10:00
The Impact of Local Asian Regulators on Private Equity Success
00:10:00
Nathan Lead, Senior Analyst at Morgans, reviews Atlas Arteria as a new addition to Morgans Best Ideas (November 2021).|Graeme Bevans is an Executive Director of ATLAX
00:10:00
Otovo CEO Andreas Thorsheim Discusses Solar Energy and Market Expansion in Europe | Andreas Egge Thorsheim, CEO , Otovo ASA.
00:10:00
Alamo Group President Advocates for Seguin Education Foundation Support | Jeff Leonard - President & Chief Executive Officer of Alamo Group, Inc.
00:10:00
Marc England Shares Investor Insights and Strategic Pathway for Genesis Energy | Marc England, CEO , Genesis Energy ltd.
00:10:00
Barnes Group: Crafting Connecticut's Success | Thomas J. Hook - President & Chief Executive Officer of Barnes
00:10:00
Gato Silver's IPO and Growth Plans in Mexico's Silver and Zinc District
00:10:00
Brett Harriss, analyst and associate portfolio manager at G Research, discusses hesitancy in investing in streaming on "Power Lunch."

© 2017 - Neuhu+